TrademarkDir
REPREFI
LIVE

Serial Number

79220436

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 29, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

REPREFI Trademark

Serial Number: 79220436 • Registration: 5603683

REPREFI is a trademark filed by NOVARTIS AG on August 29, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 29, 2017

Registration Date

November 13, 2018

Published for Opposition

August 28, 2018

Cancellation Date

January 21, 2022

Goods & Services

antifungal preparations; antivirals; cardiovascular pharmaceuticals; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 5, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Feb 5, 2022 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 15, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 26, 2019 FICS
FINAL DISPOSITION PROCESSED
Feb 26, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 13, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 13, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 28, 2018 NPUB
PUBLISHED FOR OPPOSITION
Aug 28, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Aug 24, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 8, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 8, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 8, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 18, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 13, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 13, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 13, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 3, 2018 GNFN
FINAL REFUSAL E-MAILED
Feb 3, 2018 GNFR
FINAL REFUSAL WRITTEN
Feb 3, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 5, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 4, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 4, 2018 TROA
REFUSAL PROCESSED BY IB
Dec 23, 2017 RFNP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 11, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 11, 2017 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 4, 2017 RFCS
REFUSAL PROCESSED BY MPU
Dec 4, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 23, 2017 RFCR
NON-FINAL ACTION WRITTEN
Nov 22, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 21, 2017 MAFR
ASSIGNED TO EXAMINER
Nov 20, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 15, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 9, 2017 REPR

Related Trademarks

More from this Owner

VAYBETRY

VAYBETRY

JOLBETZY

JOLBETZY

BEXJUXI

BEXJUXI

VOBYXA

VOBYXA

VISANSTA

VISANSTA

VISANSTA

VISANSTA